Bcl-2 and the ICE family of apoptotic regulators: Making a connection

Current Opinion in Genetics and Development

Volumn 7, Issue 1, 1997, Pages 52-58

  Rao, Lakshmi ^a   White, Eileen ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; PROTEIN; PROTEINASE;

APOPTOSIS; CANCER; CELL PROTECTION; GENE TRANSLOCATION; HOMEOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; VIRUS INFECTION;

INVERTEBRATA; VERTEBRATA;

EID: 0031048545     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80109-8     Document Type: Article

References (60)

1. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal break-point of the t(14:18) human lymphomas; clustering around JH on Chromosome 14 and near a transcriptional unit on 18. Cell. 41:1985;889-906.
2. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B cell neoplasms result from mistakes in VDJ joining. Science. 229:1985;1390-1393.
3. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active loucus on chromosome 18. Proc Natl Acad Sci USA. 82:1985;7439-7443.
4. Nuez G, London L, Hockenbery D, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Immunol. 144:1990;3602-3610.
5. Vaux DL, Cory S, Adams TM. Bcl-2 promotes the survival of haemopoietic cells and coopeerates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
6. White E. Life, death, and the pursuit of apoptosis. of outstanding interest Genes Dev. 10:1996;1-15 An exhaustive review of all the regulators of apoptosis; a must read.
7. Oltvai ZN, Millman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
8. Oltavi ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell. 79:1994;189-192.
9. Yin X-M, Oltvai Z, Korsmeyer S. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 396:1994;321-323.
10. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.
11. Ellis H, Horvitz HR. Genetic control of programmed cell death in in the nematode C. elegans. Cell. 44:1986;817-829.
12. Ellis HM, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol. 7:1991;663-698.
13. Nakayama K-I, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science. 261:1993;1584-1588.
14. Kamada S, Shinto AA, Tsujimura Y, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y. Bcl-2 deficiency in mice leads to pleiotropic abnormalities; accelerated lymphoid cell death in the thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55:1995;354-359.
15. Knudson CM, Tung K, Brown G, Korsmeyer SJ. Bax-deficient mice demonstrate lympoid hyperplasia but male germ cell death. of special interest Science. 270:1995;96-99 The authors of this paper describe Bax knockout mice which display hyperplasia in thymocytes and B cells and, surprisingly, the onset of make germ cell death. The cell lineages affected in Bax-deficient mice differ from those in Bcl-2-deficient mice consistent with the structural and functional redundancy among the Bcl-2 family members.
16. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY. Targeted disruption of bcl-2 alpha beta in mice - occurrence of grey hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA. 91:1994;3700-3704.
17. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
18. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homolgue Bak. Nature. 374:1995;736-739.
19. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
20. Chittenden T, Flemmington C, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G, Lutz RJ. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein-binding functions. of outstanding interest EMBO J. 14:1995;5589-5596 Using deletion mutants of Bak (a death-inducing member of the Bcl-2 family), a conserved domain, distinct from the previously described BH1 and BH2 domains, is defined. The 27 amino acid region of Bak is sufficient for protein - protein interactions and cytotoxicity indicating this to be the functionally significant region of at least some Bcl-2 family members.
21. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
22. L. Nature. 379:1996;554-556.
23. White E. Function of the adenovirus E1B oncogene in infected and transformed cells. Fanning E. Seminars in Virology. 1994;341-348 Academic Press, London.
24. Han J, Sabbatini P, Perez D, Rao L, Mohda D, White E. The E1B 19K protein functions as an apoptosis inhibitor by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. of outstanding interest Genes Dev. 10:1996;461-477 A description of the interaction between E1B 19K (the adenovirus homologue of Bcl-2) and Bax, indicating that the method of cell death inhibition by E1B 19K is a lesson borrowed from the intrinsic cellular mechanism. Remarkably, the minimum region for the binding between E1B 19K and Bax is a small 28 amino acid region of outside BH1 and BH2 and is designated BH3. Together with [20] a new domain was defined for the Bcl-2 family of proteins and interaction between the members of the Bcl-2 family was shown to be mediated by BH3, a region distinct from BH1 and BH2.
25. Hunter JJ, Parslow TG. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J Biol Chem. 271:1996;8521-8524.
26. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ. Bik1, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. of special interest Oncogene. 11:1995;1921-1928 Here, the authors describe the cloning of gene for a novel death-inducing protein, Bik, using the two-hybrid system for Bcl-2-binding proteins.
27. Han J, Sabbatini P, White E. Induction of apoptosis by human Nbk/Bik, a BH3-containing E1B 19K interacting protein. of special interest Mol Cell Biol. 16:1996;5857-5864 The cloning of a novel Bcl-2 family member using the two-hybrid system to isolate E1B 19K-interacting proteins. Nbk and Bik are identical and novel death-inducing proteins identified in [25,27] and Nbk/Bik is unique from other Bcl-2 family members as it contains only the BH3 domain but is both cytotoxic and has the ability to bind Bcl-2.
28. L; the first structure determined of any Bcl-2 family member.
29. Fraser A, Evan G. A license to kill. of outstanding interest Cell. 85:1996;781-784 A recent review, focussing on ICE-related proteases in general and TNF-R1 and FAS-mediated apoptosis in particular.
30. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
31. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier G, Salvesen GS, Dixit VM. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
32. Fernandes-Alnemri T, Litwack G, Alnemri ES. Mch2, a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res. 55:1995;2737-2742.
33. Tewari M, Dixit VM. Fas- and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem. 270:1995;3255-3260.
34. Xue D, Horvitz HR. Inhibition of the Ceanorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature. 377:1995;248-251.
35. Miura M, Friedlander RM, Yuan J. Tumor necrossis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA. 92:1995;8318-8322.
36. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P. Inhibition of ICE family proteases by baculovirus anti-apoptotic protein p35. Science. 269:1995;1885-1888.
37. Nicholson DW. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. of special interest Nat Biotechnol. 14:1996;297-301 A review outlining the pharmaceutical industry's perspective of ICE related proteases and their inhibitors.
38. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature. 356:1992;768-774.
39. Lazebnik Y, Takahashi A, Moir R, Goldman R, Poirier G, Kaufmann S, Earnshaw W. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. of special interest Proc Natl Acad Sci USA. 92:1995;9042-9046 Analysis of lamin cleavage in a cell-free system demonstrates that an ICE-like protease with different kinetics of cleavage and profile of sensitivity than that of the PARP-cleaving protease is responsible for lamin cleavage. This leads the authors to conclude that multiple but parallel protease pathways are activated during the execution of apoptosis.
40. Enari M, Talanian VR, Wong W, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during FAS-mediated apoptosis. of special interest Nature. 380:1996;723-726 Using the cell-free approach and chemical inhibitors of ICE family proteases, the authors dissect the FAS-mediated apoptotic pathway and conclude that both ICE-like and CPP32-like proteases are sequentially activated. References [39,40] provide evidence for the involvement of multiple proteases during the execution of apoptosis; whether this is in sequence or in parallel is contestable.
41. Tewari M, Dixi VM. Recent advances in tumor necrosis factor and CD40 signaling. Curr Opin Genet Dev. 6:1996;39-44.
42. Tartaglia LA, Ayers TM, Wong GHW, Goeddel DV. A novel domain within the 55kDa TNF receptor signals cell death. Cell. 74:1993;845-853.
43. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 270:1995;7795-7798.
44. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;512-805.
45. Cleveland JL, Ihle JN. Contenders in FasL/TNF death signaling. Cell. 81:1995;479-482.
46. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NFB activation. Cell. 81:1995;495-504.
47. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B. RIP: A novel protein containing a death domain that interacts with FAS/Apo-1 (CD95) in yeast and causes cell death. Cell. 81:1995;513-523.
48. L and is accompanied by the activation of ICE-like proteases. Using this information, the authors attempt to define a pathway leading to apoptosis by ordering the role of the players involved. Significantly, this study places Bcl-2 family members upstream of ICE family proteases in the apoptotic pathway.
49. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
50. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle P, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:1995;81-83.
51. Schlegel J, Peters I, Orrenius S, Miller D, Thornberry N, Yamin T-T, Nicholson D. CPP32/Apopain is a key Interleukin-1β-converting enzyme-like protease involved in FAS-mediated apoptosis. J Biol Chem. 271:1996;1841-1844.
52. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. of outstanding interest Cell. 85:1996;817-827 Description of a novel protein, FLICE, recruited to the CD95 receptor complex during FAS-induced apoptosis.
53. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. of outstanding interest Cell. 85:1996;803-815 A description of the cloning of a gene for the novel protein, MACH, using the two-hybrid approach for isolating MORT1-binding proteins. MACH and FLICE, described in [52,53], are the same protein and contain a 'death-effector domain' which is shown to associate with other 'death-effector domain' containing proteins. The carboxy-terminal 260 amino acids of MACH/FLICE function as an ICE-like protease. This gives direct evidence for the involvement of ICE-like proteases in FAS-induced apoptosis.
54. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
55. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann K, Conn CA, Soszynski D, Grablec C, Trumbauer M, Shaw A. Resistance to fever induction and Impaired acute phase response in interleukin-1β-deficient mice. Immunity. 3:1995;9-19.
56. Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. Mice lacking ADPRT and poly(ADP) ribosylation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;509-520.
57. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. of special interest J Cell Biol. 135:1996;1441-1456 Using cleavage site mutants of lamins which are resistant to proteolysis, the authors of this paper provide evidence that lamins may be an important and early substrate for ICE-like proteases during apoptosis.
58. Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC. Cleavage of lamin A by Mch2α but not CPP32: multiple ICE-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci US. 93:1996;8395-8400.
59. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG, Shore GC. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene. 12:1996;529-535.
60. White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI, Gooding L. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α Mol Cell Biol. 12:1992;2570-2580.